A Network Meta-Analysis of Randomized, Controlled Trials of Ustekinumab and Adalimumab for Moderate-To-Severe Psoriasis
Odom, D., Brogan, A., Talbird, S., & Schenkel, B. (2013). A Network Meta-Analysis of Randomized, Controlled Trials of Ustekinumab and Adalimumab for Moderate-To-Severe Psoriasis. Value in Health, 16(3), A112-A112.
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Meet the Experts
View All ExpertsRecent Publications
Article
Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Article
Community overdose surveillance
Article
Epigenetic biomarkers for smoking cessation
Article